Matthew Lloyd
Novo Nordisk Postdoctoral Research Fellow
Research
My research aims to determine the molecular mechanisms by which readers of histone modifications confer circadian rhythmicity onto downstream metabolic pathways to control glucose and lipid homeostasis. Understanding these processes promises to unlock novel anti-obesity therapies.